PCF11
Pre-mRNA cleavage complex 2 protein Pcf11
Also known as: KIAA0824, PCF11_HUMAN
Cross-references: UniProt · Ensembl · Human Protein Atlas · GeneCards · NCBI Gene
Protein identityUniProt · HPA
- UniProt accession
- O94913
- Gene
- PCF11
- Ensembl
- ENSG00000165494
- Chromosome
- 11
- Canonical length
- 1555 aa
- Protein class
- Plasma proteins, Predicted intracellular proteins
- Subcellular location
- Nucleoplasm,Mitochondria
OverviewNCBI Gene
The protein encoded by this gene binds to CLP1 to form pre-mRNA cleavage factor IIm. The encoded protein is necessary for efficient Pol II transcription termination and may be involved in degradation of the 3' product of polyA site cleavage. [provided by RefSeq, Oct 2016]
Canonical amino-acid sequenceUniProt
1555 residues, UniProt reviewed canonical sequence.
>O94913|PCF11
1 MSEQTPAEAG AAGAREDACR DYQSSLEDLT FNSKPHINML TILAEENLPF AKEIVSLIEA
61 QTAKAPSSEK LPVMYLMDSI VKNVGREYLT AFTKNLVATF ICVFEKVDEN TRKSLFKLRS
121 TWDEIFPLKK LYALDVRVNS LDPAWPIKPL PPNVNTSSIH VNPKFLNKSP EEPSTPGTVV
181 SSPSISTPPI VPDIQKNLTQ EQLIRQQLLA KQKQLLELQQ KKLELELEQA KAQLAVSLSV
241 QQETSNLGPG SAPSKLHVSQ IPPMAVKAPH QVPVQSEKSR PGPSLQIQDL KGTNRDPRLN
301 RISQHSHGKD QSHRKEFLMN TLNQSDTKTS KTIPSEKLNS SKQEKSKSGE KITKKELDQL
361 DSKSKSKSKS PSPLKNKLSH TKDLKNQESE SMRLSDMNKR DPRLKKHLQD KTDGKDDDVK
421 EKRKTAEKKD KDEHMKSSEH RLAGSRNKII NGIVQKQDTI TEESEKQGTK PGRSSTRKRS
481 RSRSPKSRSP IIHSPKRRDR RSPKRRQRSM SPTSTPKAGK IRQSGAKQSH MEEFTPPSRE
541 DRNAKRSTKQ DIRDPRRMKK TEEERPQETT NQHSTKSGTE PKENVENWQS SKSAKRWKSG
601 WEENKSLQQV DEHSKPPHLR HRESWSSTKG ILSPRAPKQQ QHRLSVDANL QIPKELTLAS
661 KRELLQKTSE RLASGEITQD DFLVVVHQIR QLFQYQEGVR EEQRSPFNDR FPLKRPRYED
721 SDKPFVDSPA SRFAGLDTNQ RLTALAEDRP LFDGPSRPSV ARDGPTKMIF EGPNKLSPRI
781 DGPPTPASLR FDGSPGQMGG GGPLRFEGPQ GQLGGGCPLR FEGPPGPVGT PLRFEGPIGQ
841 AGGGGFRFEG SPGLRFEGSP GGLRFEGPGG QPVGGLRFEG HRGQPVGGLR FEGPHGQPVG
901 GLRFDNPRGQ PVGGLRFEGG HGPSGAAIRF DGPHGQPGGG IRFEGPLLQQ GVGMRFEGPH
961 GQSVAGLRFE GQHNQLGGNL RFEGPHGQPG VGIRFEGPLV QQGGGMRFEG PSVPGGGLRI
1021 EGPLGQGGPR FEGCHALRFD GQPGQPSLLP RFDGLHGQPG PRFERTPGQP GPQRFDGPPG
1081 QQVQPRFDGV PQRFDGPQHQ QASRFDIPLG LQGTRFDNHP SQRLESVSFN QTGPYNDPPG
1141 NAFNAPSQGL QFQRHEQIFD SPQGPNFNGP HGPGNQSFSN PLNRASGHYF DEKNLQSSQF
1201 GNFGNIPAPM TVGNIQASQQ VLSGVAQPVA FGQGQQFLPV HPQNPGFVQN PSGALPKAYP
1261 DNHLSQVDVN ELFSKLLKTG ILKLSQTDSA TTQVSEVTAQ PPPEEEEDQN EDQDVPDLTN
1321 FTVEELKQRY DSVINRLYTG IQCYSCGMRF TTSQTDVYAD HLDWHYRQNR TEKDVSRKVT
1381 HRRWYYSLTD WIEFEEIADL EERAKSQFFE KVHEEVVLKT QEAAKEKEFQ SVPAGPAGAV
1441 ESCEICQEQF EQYWDEEEEE WHLKNAIRVD GKIYHPSCYE DYQNTSSFDC TPSPSKTPVE
1501 NPLNIMLNIV KNELQEPCDS PKVKEERIDT PPACTEESIA TPSEIKTEND TVESVLocalizationUniProt · AlphaFold · HPA
Whether an antibody against PCF11 can act on the native protein depends on physical access: surface and secreted proteins are reachable by circulating antibodies, intracellular proteins usually are not.
- Antibody reachability
- Intracellular
- Secreted
- No
- Transmembrane segments
- 0
- Mean surface accessibility (rSASA)
- 0.6
- Highest tissue expression
- 31 nTPM
Expression across tissuesHPA
Tissue
- bone marrow: 31 nTPM
- thymus: 29 nTPM
- lymph node: 27 nTPM
- tonsil: 26 nTPM
- spleen: 25 nTPM
- skin: 22 nTPM
Single-cell type
- neutrophils: 308 nCPM
- early spermatids: 232 nCPM
- neutrophil progenitors: 160 nCPM
- epididymal basal cells: 147 nCPM
- esophageal apical cells: 140 nCPM
- b-cells: 129 nCPM
Immune cell
- neutrophil: 17 nTPM
- eosinophil: 14 nTPM
- basophil: 14 nTPM
- NK-cell: 13 nTPM
- memory B-cell: 10 nTPM
- naive B-cell: 9.3 nTPM
Brain region
- cerebellum: 68 nTPM
- white matter: 44 nTPM
- basal ganglia: 39 nTPM
- pons: 39 nTPM
- medulla oblongata: 38 nTPM
- midbrain: 36 nTPM
Genetic constraint and essentialitygnomAD · DepMap
Does the body need this protein intact? Low LOEUF or a strong DepMap dependency means loss or blockade of the protein is likely to be felt.
- gnomAD LOEUF (loss-of-function intolerance)
- 0.04
- gnomAD pLI
- 1
- gnomAD missense Z
- 2.66
- DepMap mean gene effect
- -1.04
- DepMap dependency class
- common
Cancer expressionTCGA
Across TCGA tumor cohorts, this protein is over-expressed in roughly 4% of surveyed tumor types (aggregate summary; per-cohort expression, alteration, and survival load in the interactive view).
OntologyGO
Biological processes
- co-transcriptional mRNA 3'-end processing, cleavage and polyadenylation pathway
- termination of RNA polymerase II transcription
Molecular functions
Cellular components
Protein domainsUniProt · Pfam · InterPro
- CID domain
- ENTH/VHS
- CID domain
- Pcf11, Clp1-ID
- Protein PCF11-like
- Pcf11, CID domain
- Pre-mRNA cleavage complex 2 protein Pcf11, RFEGP repeat
- Pre-mRNA cleavage complex 2 protein Pcf11, helical domain
- PCF11, charged region
- Pcf11, C-terminal domain
- Pcf11, Clp1-interaction domain
- PCF11, charged region
- Pre-mRNA cleavage complex 2 protein Pcf11, RFEGP repeat
- Pre-mRNA cleavage complex 2 protein Pcf11, alpha-helical domain
- Pcf11, C-terminal domain
KeywordsUniProt
InteractionsUniProt · HPA
Protein binding partners of PCF11 in the human serome: UniProt-annotated complex subunits plus reported interactors. Each links to its own Seroatlas record.
Antibody and autoantibody relevanceSeroatlas analysis
Seroatlas reads PCF11 as an antibody target. Whether an autoantibody or antibody against PCF11 could matter depends on whether native PCF11 is physically reachable, whether the body needs it intact, and whether it acts in a disease-relevant tissue.
PCF11 is annotated as predominantly intracellular. Intracellular proteins are common autoantibody markers, becoming visible to the immune system after cell injury or altered processing, but are usually markers of disease rather than direct drivers.
Annotation status
The present source text does not explicitly label PCF11 as an autoantigen. Seroatlas presents hypothesis context only and does not manufacture a known-serology claim.
Loading the interactive Seroatlas protein explorer...